生物技术的数字化转型:生物技术公司的竞争优势

Yang Weibo
{"title":"生物技术的数字化转型:生物技术公司的竞争优势","authors":"Yang Weibo","doi":"10.5912/jcb1329","DOIUrl":null,"url":null,"abstract":"Digital transformation in biotech is the competitive advantage in the biotech industry. It has made life easier for them and their customers, bringing efficiency to all levels of the company and collecting data, product quality, and predictability to all sectors of life. It’s been argued over many years that a lack of vision led to a lack of competitiveness in this industry. The old ways were bearing fruit; these days gone by, there is a need for new strategies where large pharmaceutical companies are struggling with their market share going down while small biotech firms are growing exponentially. The future is data and digital transformation. Digital transformation in biotech is a massive trend that has affected the lives of all humans.  Even though, it’s a new concept in this industry, that has no official definition yet. Hence, it’s been heavily debated over many years by many scholars and companies on how to define digital transformation in biotech. Digital technologies are changing the way we work and interact with. Digitization of the pharmaceutical industry is one of the biggest challenges for drug firms, who have to deal with the onslaught of pressures from cost-conscious consumers who, along with lawmakers, are chasing incontrovertible evidence of benefits from drug side effects and cost savings from data-driven healthcare.","PeriodicalId":88541,"journal":{"name":"Journal of commercial biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Digital Transformation In Biotech: The Competitive Advantage In Biotech Companies\",\"authors\":\"Yang Weibo\",\"doi\":\"10.5912/jcb1329\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Digital transformation in biotech is the competitive advantage in the biotech industry. It has made life easier for them and their customers, bringing efficiency to all levels of the company and collecting data, product quality, and predictability to all sectors of life. It’s been argued over many years that a lack of vision led to a lack of competitiveness in this industry. The old ways were bearing fruit; these days gone by, there is a need for new strategies where large pharmaceutical companies are struggling with their market share going down while small biotech firms are growing exponentially. The future is data and digital transformation. Digital transformation in biotech is a massive trend that has affected the lives of all humans.  Even though, it’s a new concept in this industry, that has no official definition yet. Hence, it’s been heavily debated over many years by many scholars and companies on how to define digital transformation in biotech. Digital technologies are changing the way we work and interact with. Digitization of the pharmaceutical industry is one of the biggest challenges for drug firms, who have to deal with the onslaught of pressures from cost-conscious consumers who, along with lawmakers, are chasing incontrovertible evidence of benefits from drug side effects and cost savings from data-driven healthcare.\",\"PeriodicalId\":88541,\"journal\":{\"name\":\"Journal of commercial biotechnology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of commercial biotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5912/jcb1329\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of commercial biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5912/jcb1329","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

生物技术的数字化转型是生物技术行业的竞争优势。它让他们和他们的客户的生活更轻松,为公司的各个层面带来了效率,并为生活的各个部门收集数据、产品质量和可预测性。多年来,人们一直认为,缺乏远见会导致这个行业缺乏竞争力。旧的方式正在结出果实;这些天过去了,人们需要新的战略,大型制药公司正在努力应对市场份额下降的问题,而小型生物技术公司正在呈指数级增长。未来是数据和数字化转型。生物技术的数字化转型是一个巨大的趋势,已经影响到所有人类的生活。尽管这是这个行业的一个新概念,但还没有官方定义。因此,多年来,许多学者和公司就如何定义生物技术的数字化转型进行了激烈的辩论。数字技术正在改变我们的工作方式和互动方式。制药行业的数字化是制药公司面临的最大挑战之一,他们必须应对有成本意识的消费者的压力,这些消费者和立法者正在寻找无可争议的证据,证明药物副作用的好处和数据驱动的医疗保健的成本节约。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Digital Transformation In Biotech: The Competitive Advantage In Biotech Companies
Digital transformation in biotech is the competitive advantage in the biotech industry. It has made life easier for them and their customers, bringing efficiency to all levels of the company and collecting data, product quality, and predictability to all sectors of life. It’s been argued over many years that a lack of vision led to a lack of competitiveness in this industry. The old ways were bearing fruit; these days gone by, there is a need for new strategies where large pharmaceutical companies are struggling with their market share going down while small biotech firms are growing exponentially. The future is data and digital transformation. Digital transformation in biotech is a massive trend that has affected the lives of all humans.  Even though, it’s a new concept in this industry, that has no official definition yet. Hence, it’s been heavily debated over many years by many scholars and companies on how to define digital transformation in biotech. Digital technologies are changing the way we work and interact with. Digitization of the pharmaceutical industry is one of the biggest challenges for drug firms, who have to deal with the onslaught of pressures from cost-conscious consumers who, along with lawmakers, are chasing incontrovertible evidence of benefits from drug side effects and cost savings from data-driven healthcare.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信